DFX Intelligence

Data Factory

Private equityFirmbuyoutlower middle market

Cambridge Innovation Capital Manager Limited

Private Equity

Cambridge, Cambs

We are driven by people and ideas. As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision. Cambridge Innovation Capital

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:ca47e35a-26a2-42ad-bb0c-6b5253494745

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 21, 2026, 9:38 AM UTC and rebuilt at most every 15 minutes.

Relationships: 42
Dated events: 3
On other graphs: 0
Observed: Sep 13, 2026 to Sep 17, 2026
31 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 2
PE funds: 2
PE GAV, 2024 filing: $278Mgross asset value on Form ADV; never dry powder
Investments: 38
Active investments: 0
Size band: LOWER MIDDLE MARKETderivedproxy: $0.28bn Private Equity Fund GAV on the Form ADV filed 2024-05-07
Stated sectors: technology
Latest ADV filing: May 7, 2024
Website: cic.vc

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV	LPs
Cambridge Innovation Capital II (usd) LP	n/a	Unknown	Private Equity Fund	n/a	$40.6M	0
Cambridge Innovation Capital II LP	n/a	Unknown	Private Equity Fund	n/a	$238M	0

Investments

Company	State	Role	Control	Invested	Exited	Status
Abcodia	n/a	unknown	unknown	n/a	n/a	unknown
Audio Analytic	n/a	unknown	unknown	n/a	n/a	unknown
BeyondMath	n/a	unknown	unknown	n/a	n/a	unknown
Bicycle Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Cambridge GaN Devices	n/a	unknown	unknown	n/a	n/a	unknown
Carrick Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
CMR Surgical	n/a	unknown	unknown	n/a	n/a	unknown
Complement Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Congenica	n/a	unknown	unknown	n/a	n/a	unknown
Cytora	n/a	unknown	unknown	n/a	n/a	unknown
Epitopea	n/a	unknown	unknown	n/a	n/a	unknown
Forefront RF	n/a	unknown	unknown	n/a	n/a	unknown
Gyroscope Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Imagen	n/a	unknown	unknown	n/a	n/a	unknown
Immutrin Limited	n/a	unknown	unknown	n/a	n/a	unknown
Inivata	n/a	unknown	unknown	n/a	n/a	unknown
Microbiotica	n/a	unknown	unknown	n/a	n/a	unknown
Morphogen-IX	n/a	unknown	unknown	n/a	n/a	unknown
Mosaic Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Nuclera	n/a	unknown	unknown	n/a	n/a	unknown
PetMedix	n/a	unknown	unknown	n/a	n/a	unknown
Pragmatic Semiconductor	n/a	unknown	unknown	n/a	n/a	unknown
Pretzel Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown
Riverlane	n/a	unknown	unknown	n/a	n/a	unknown
Salience Labs	n/a	unknown	unknown	n/a	n/a	unknown
Secondmind	n/a	unknown	unknown	n/a	n/a	unknown
Seldon	n/a	unknown	unknown	n/a	n/a	unknown
Sense Biodetection	n/a	unknown	unknown	n/a	n/a	unknown
Sortera Bio	n/a	unknown	unknown	n/a	n/a	unknown
STORM Therapeutics	n/a	unknown	unknown	n/a	n/a	unknown

Relationships

Invested in (38)

→ SecondmindCompanyunknown
factThe subject's own site
→ AbcodiaCompanyunknown
factThe subject's own site
→ Audio AnalyticCompanyunknown
factThe subject's own site
→ BeyondMathCompanyunknown
factThe subject's own site
→ Bicycle TherapeuticsCompanyunknown
factThe subject's own site
→ Cambridge GaN DevicesCompanyunknown
factThe subject's own site
→ Carrick TherapeuticsCompanyunknown
factThe subject's own site
→ CMR SurgicalCompanyunknown
factThe subject's own site
→ Complement TherapeuticsCompanyunknown
factThe subject's own site
→ CongenicaCompanyunknown
factThe subject's own site
→ CytoraCompanyunknown
factThe subject's own site
→ EpitopeaCompanyunknown
factThe subject's own site
→ Forefront RFCompanyunknown
factThe subject's own site
→ Gyroscope TherapeuticsCompanyunknown
factThe subject's own site
→ ImagenCompanyunknown
factThe subject's own site
→ Immutrin LimitedCompanyunknown
factThe subject's own site
→ InivataCompanyunknown
factThe subject's own site
→ MicrobioticaCompanyunknown
factThe subject's own site
→ Morphogen-IXCompanyunknown
factThe subject's own site
→ Mosaic TherapeuticsCompanyunknown
factThe subject's own site
→ NucleraCompanyunknown
factThe subject's own site
→ PetMedixCompanyunknown
factThe subject's own site
→ Pragmatic SemiconductorCompanyunknown
factThe subject's own site
→ Pretzel TherapeuticsCompanyunknown
factThe subject's own site
→ RiverlaneCompanyunknown
factThe subject's own site
→ Salience LabsCompanyunknown
factThe subject's own site
→ SeldonCompanyunknown
factThe subject's own site
→ Sense BiodetectionCompanyunknown
factThe subject's own site
→ Sortera BioCompanyunknown
factThe subject's own site
→ STORM TherapeuticsCompanyunknown
factThe subject's own site
and 8 more

Manages (2)

→ Cambridge Innovation Capital II (usd) LPFundPrivate Equity Fund
Sep 3, 2021 to presentfactForm ADV
→ Cambridge Innovation Capital II LPFundPrivate Equity Fund
Sep 3, 2021 to presentfactForm ADV

Owns (2)

← University of CambridgeFirmShareholder
Nov 1, 2012 to presentfactForm ADV
← Cambridge Innovation Capital LimitedFirmShareholder
May 1, 2019 to presentfactForm ADV

Dated events

2 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Sep 3, 2021
Adviser first adv filing
Cambridge Innovation Capital Manager Limited first filed Form ADV in the extract (ERA)
Form ADVobserved 7 days ago

Show 2 bookkeeping events

Occurred
Sep 3, 2021
Cambridge Innovation Capital II (usd) LP first reported on Form ADV by Cambridge Innovation Capital Manager Limited (Private Equity Fund), GAV $35,600,000
Occurred
Sep 3, 2021
Cambridge Innovation Capital II LP first reported on Form ADV by Cambridge Innovation Capital Manager Limited (Private Equity Fund), GAV $65,704,823

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV), 1 website (Form ADV), 2 work emails (firm website) · as of 2026-09-17

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan